Pharma news
Americas
The Patent Trial and Appeal Board has invalidated claims in two Teva-owned patents covering Copaxone, prompting the Israel-based company to announce its intention to appeal against the ruling. 25 August 2016
Americas
Drug prices are increasing significantly in the US due to government regulations, including surrounding patents and market exclusivity, according to a new study. 24 August 2016
Americas
Although recent Federal Circuit decisions on the ‘patent dance’ provide some clarity, the BPCIA still presents difficult and hotly debated issues of interpretation. Stacie Ropka, William Rose and Ryan Hersh of Axinn, Veltrop & Harkrider report. 23 August 2016
Pharma
Gilead Sciences has received marketing authorisation from the European Commission for its drug Truvada. 23 August 2016
Americas
AstraZeneca and Eli Lilly have received US Food and Drug Administration fast track designation for the development of a treatment for Alzheimer’s. 23 August 2016
Americas
Pfizer has unveiled plans to acquire US based biopharmaceutical company Medivation for approximately $14 billion. 22 August 2016
Americas
Horizon Pharma has sued Actavis for allegedly infringing four of its patents. 19 August 2016
Pharma
Teva announced today that the European Commission has granted marketing authorisation for Cinqaero following an efficacy probe. 18 August 2016
Americas
Xycrobe Therapeutics revealed yesterday, August 17, that it has entered into a research agreement with pharmaceutical company Johnson & Johnson. 17 August 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of the US Patent and Trademark Office that a patent challenged by Apotex is valid. 17 August 2016